REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

HMD BioMedical Inc. (厚美德生物科技股份有限公司) (Taiwan, China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: HMD BioMedical Inc. Profile Updated: January 27, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Chinese Download a sample report

HMD BioMedical Inc is a medical biotechnology company that specializes in the research, development, and manufacturing of blood glucose monitoring systems. Its primary target market is the diabetes care sector, and it offers products under the brand name "GlucoLeader." HMD BioMedical claims to be the first MDSAP certified company in Taiwan.

Headquarters
No.181, Minsheng St. Xinpu Township
Hsinchu City; Hsinchu City;

Contact Details: Purchase the HMD BioMedical Inc. (厚美德生物科技股份有限公司) report to view the information.

Website: http://www.hmdbio.com

Basic Information
Total Employees:
Purchase the HMD BioMedical Inc. (厚美德生物科技股份有限公司) report to view the information.
Outstanding Shares:
Purchase the HMD BioMedical Inc. (厚美德生物科技股份有限公司) report to view the information.
Financial Auditors:
Purchase the HMD BioMedical Inc. (厚美德生物科技股份有限公司) report to view the information.
Incorporation Date:
May 15, 2000
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
7.17%
Purchase this report to view the information.
4.92%
Purchase this report to view the information.
4.73%
Purchase this report to view the information.
4.4%
Purchase this report to view the information.
4.11%
Subsidiaries
1St Choice Co.,Ltd.
100%
Borvo Health, Inc. (United Kingdom)
85%
Company Performance
Financial values in the chart are available after HMD BioMedical Inc. (厚美德生物科技股份有限公司) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TWD. Absolute financial data is included in the purchased report.
Net sales revenue
-8.06%▼
Total operating revenue
-11.41%▼
Operating Profit/Loss (EBIT)
N/A
EBITDA
-55.41%▼
Net Profit/Loss for the Period
N/A
Total Assets
-8.33%▼
Total Equity
-3.22%▼
Operating Profit Margin (ROS)
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Debt/Equity
3.94%▲
Quick Ratio
0.18%▲
Cash Ratio
0.08%▲

Similar companies

Bora Pharmaceuticals Co., Ltd.
 
Lotus Pharmaceutical Co., Ltd.
Great Tree Pharmacy Co.,Ltd.
 
PharmaEssentia Corp.
Cenra Inc.
 
China Chemical & Pharmaceutical Co., Ltd
UBI Pharma Inc.
 
GeneFerm Biotechnology Co., Ltd.
Genovate Biotechnology Co., Ltd.
 
EPS Bio Technology Corp.
Sunny Pharmtech Inc.
 

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo